Abstract:Atherosclerosis is the leading cause of death in western countries. Lipoprotein metabolism is closely related with the disease. ApoB-containing lipoproteins (BLp) are atherogenic particles, while, high density lipoproteins (HDL) are anti-atherogenic. Phospholipids Transfer Protein (PLTP) activity has important impact on BLp and HDL homeostasis. Animal studies, including general knock out (KO) and transgenic approaches, have shown pro-atherogenic properties for PLTP. However, the tissue specific function of PLTP remains mostly unknown. To address the impact of liver-specific expression of PLTP on lipoprotein metabolism, we have created two mouse models which either express PLTP specifically in the liver on a PLTP-null background or do not express PLTP in the liver (liver-specific PLTP KO) in a wild type background. In both models, our findings show that liver-specific PLTP is responsible for 25-30% of total plasma PLTP activity. Moreover, liver-specific PLTP expression model shows a remarkable increase in plasma levels of BLp, whereas liver-specific PLTP KO mice show significant reduction of BLp in plasma in compare to control group. These results further show the significant contribution of PLTP in BLp production. We also found that HDL levels are slightly increased in the first model, while in liver-specific PLTP KO animals HDL levels are significantly decreased. In order to unravel the mechanism, we evaluated the apoB and triglyceride production rates after blocking the clearance of the particles. We found that liver-specific PLTP increases apoB (both apo48 and apoB100) and triglyceride (TG) secretion rates. Additionally, the study of the hepatocyte microsomal luminal content lipidation in the first model showed that in the presence of PLTP BLp lipidation, which reflects as higher level of TG in microsomal luminal content, is significantly higher than the control group. Our results indicate that liver-generated PLTP promotes atherogenic lipoprotein production and provides a rationale for liver-specific PLTP inhibition as a therapeutical approach for the treatment of atherosclerosis.

The Effect of Bone Marrow Derived Lipoprotein Lipase on Lipid Metabolism in Severe Lipoprotein Lipase Deficient Hypertriglyceridemic Mice

Long-Term Correction of Murine Lipoprotein Lipase Deficiency with AAV1-Mediated Gene Transfer of the Naturally Occurring LPLS447XBeneficial Mutation

Complete Rescue of Lipoprotein Lipase–Deficient Mice by Somatic Gene Transfer of the Naturally Occurring LPLS447XBeneficial Mutation

Effect of Bone Marrow Mesenchymal Stem Cells on Spleen T Lymphocyte Functions in apoE~(-/-) Mice

40. Correction of Dyslipidemia in Murine and Feline Models of Lipoprotein Lipase Deficiency by Intramuscular Administration of AAV1-LPLS447X

Spontaneous Atherosclerosis In Aged Lipoprotein Lipase-Deficient Mice With Severe Hypertriglyceridemia On A Normal Chow Diet

Abstract 330: Liver-Specific Phospholipids Transfer Protein Activity Has Significant Contribution in Hepatocyte Apob-Containing Lipoprotein Production and in Plasma Lipoprotein Metabolism

Rescue of a Lethal Mouse Model of Extreme Hypertriglyceridimia by Somatic Gene Transfer of a Beneficial LPL Mutant Gene

Regulation of Plasma Lipid Homeostasis by Hepatic Lipoprotein Lipase in Adult Mice.

Leu452His Mutation in Lipoprotein Lipase Gene Transfer Associated with Hypertriglyceridemia in Mice in Vivo

Macrophage Phospholipid Transfer Protein Deficiency and ApoE Secretion

Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia.

Effects Of Cardiotonic Pill On Rbc Rheologic Abnormalities In Hfd-Induced Mice And Lpl Deficient Mice

Effects of Phospholipid Transfer Protein Overexpression on Content of Sphingosine-1-phosphate in Mouse Lipoprotein

Liver-Specific Phospholipid Transfer Protein Deficiency Reduces High-Density Lipoprotein and Non–High-Density Lipoprotein Production in Mice

Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency

The Binding Capability of Plasma Phospholipid Transfer Protein, but Not Hdl Pool Size, is Critical to Repress Lps Induced Inflammation

The Effect of Phospholipid Transfer Protein on Lipoprotein Metabolism and Atherosclerosis

Macrophage Phospholipid Transfer Protein Contributes Significantly To Total Plasma Phospholipid Transfer Activity And Its Deficiency Leads To Diminished Atherosclerotic Lesion Development

Increased Atherosclerotic Lesions in ApoE Mice with Plasma Phospholipid Transfer Protein Overexpression

Development of Combined Hypercholesterolemic/ Hypertriglyceridemic Mouse Model